eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways

Scientific Reports
Zvi CramerImed-Eddine Gallouzi

Abstract

Cachexia is a deadly muscle wasting syndrome that arises under conditions linked to chronic inflammation, such as cancer. Cytokines, including interferon γ (IFNγ), tumor necrosis factor α (TNFα) and interleukin-6 (IL-6), and their downstream effectors such as Signal Transducer and Activator of Transcription 3 (STAT3), have been shown to play a prominent role in muscle wasting. Previously, we demonstrated that Pateamine A (PatA), a compound that targets eukaryotic initiation factor 4A (eIF4A), could prevent muscle wasting by modulating the translation of the inducible Nitric Oxide Synthase (iNOS) mRNA. Here we show that hippuristanol, a compound that impedes eIF4A in a manner distinct from PatA, similarly inhibits the iNOS/NO pathway and cytokine-induced muscle wasting. Furthermore, we show that hippuristanol perturbs the activation of the STAT3 pathway and expression of STAT3-gene targets such as IL-6. The decreased activation of STAT3, which resulted from a decrease in STAT3 protein expression, was due to the inhibition of STAT3 translation as there were no changes in STAT3 mRNA levels. These effects are likely dependent on the inhibition of eIF4A activity since we observed similar results using PatA. Our results identify the ...Continue Reading

References

May 1, 1992·The Journal of Clinical Investigation·G StrassmannC O Jacob
Aug 26, 1998·Clinical and Experimental Immunology·K D KrönckeV Kolb-Bachofen
Aug 29, 2003·The Journal of Biological Chemistry·Kate van der GiessenImed Eddine Gallouzi
Oct 14, 2004·Cell·Dongsheng CaiSteven E Shoelson
Jul 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Marie-Eve BordeleauJerry Pelletier
Mar 15, 2006·Nature Chemical Biology·Marie-Eve BordeleauJerry Pelletier
Dec 23, 2006·Chemistry & Biology·Marie-Eve BordeleauJerry Pelletier
Dec 7, 2007·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Kristen A BaltgalvisJames A Carson
Apr 4, 2009·Physiological Reviews·Michael J Tisdale
Jan 12, 2011·Biochemical Pharmacology·Tomoyuki TsumurayaNaoki Mori
Feb 8, 2011·The Lancet Oncology·Kenneth FearonVickie E Baracos
Oct 15, 2011·Expert Opinion on Biological Therapy·Trevor J BaylissJames R Rigas
Jun 7, 2012·American Journal of Physiology. Endocrinology and Metabolism·Andrea BonettoTeresa A Zimmers
Jun 14, 2012·Nature Communications·Sergio Di MarcoImed Eddine Gallouzi
Sep 6, 2013·Nature Communications·Virginie Dormoy-RacletImed-Eddine Gallouzi
Oct 15, 2013·Cell·Denes HniszRichard A Young
Mar 22, 2014·Journal of Cellular Physiology·Marine GilabertJuan Iovanna
Aug 1, 2014·Nature·Andrew L WolfeHans-Guido Wendel
Sep 18, 2014·Nature Communications·Fernando Valiente-EcheverríaAndrew J Mouland
Sep 23, 2014·Biochimica Et Biophysica Acta·Jennifer Chu, Jerry Pelletier
Oct 17, 2014·Current Opinion in Supportive and Palliative Care·Aditi A Narsale, James A Carson
Oct 25, 2014·Nature Reviews. Cancer·Hua YuRichard Jove
Jan 17, 2015·Cancer Research·Jerry PelletierNahum Sonenberg
Apr 22, 2015·World Journal of Gastrointestinal Oncology·Tomoyoshi AoyagiKazuaki Takabe
May 15, 2015·Current Opinion in Pharmacology·Josep M ArgilésFrancisco J López-Soriano
Jun 27, 2015·The Journal of Endocrinology·Maria Carolina S MendesJosé B C Carvalheira
Feb 11, 2016·Seminars in Cell & Developmental Biology·Teresa A ZimmersAndrea Bonetto
Mar 6, 2016·Genes & Development·Michele Petruzzelli, Erwin F Wagner
Nov 20, 2016·Antiviral Research·Nadine BiedenkopfArnold Grünweller
Mar 8, 2017·EMBO Molecular Medicine·Jennifer F MaImed-Eddine Gallouzi

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
footprinting

Related Concepts

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.